Assoumou is an infectious diseases physician-scientist at Boston Medical Center. Miller is a research data associate within Dr. Assoumou’s I-CARE (Infectious Complications Assessment and Research) lab ...
HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...
The long fight against HIV/AIDS may get a potent new weapon. A new drug, taken by injection twice a year, shows great promise in preventing new HIV infections and would ease the treatment process ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
The World Health Organization's (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the ...
In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful. Today, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback